Initial studies indicate that the compound – a dual stimulator of incretin and a related hormone receptors – offers a substantial advance in weight reduction programs . Unlike existing medications , the peptide seems to modify appetite and calorie burn via distinct mechanisms . Despite more investigation is required , the results raise optimis